Lamivudine/tenofovir was approved for medical use in the United States in February 2018.[1][4]
References
^ abcde"Cimduo- lamivudine and tenofovir disoproxil fumarate tablet, film coated". DailyMed. 22 March 2018. Retrieved 26 March 2020.
^"Temixys- lamivudine and tenofovir disoproxil fumarate tablet, film coated". DailyMed. Retrieved 13 February 2022.
^Waters L, Mehta V, Gogtay J, Boffito M (March 2021). "The evidence for using tenofovir disoproxil fumarate plus lamivudine as a nucleoside analogue backbone for the treatment of HIV". Journal of Virus Eradication. 7 (1): 100028. doi:10.1016/j.jve.2021.100028. PMC7868802. PMID 33598310.
^"Drug Approval Package: Cimduo (lamivudine and tenofovir disoproxil fumarate)". U.S. Food and Drug Administration (FDA). 27 November 2018. Retrieved 26 March 2020.
lamivudine, tenofovir, this, article, relies, excessively, references, primary, sources, please, improve, this, article, adding, secondary, tertiary, sources, find, sources, news, newspapers, books, scholar, jstor, march, 2020, learn, when, remove, this, templ. This article relies excessively on references to primary sources Please improve this article by adding secondary or tertiary sources Find sources Lamivudine tenofovir news newspapers books scholar JSTOR March 2020 Learn how and when to remove this template message Lamivudine tenofovir disoproxil sold under the brand name Cimduo among others is a fixed dose combination antiretroviral medication for the treatment of HIV AIDS in adults and children weighing more than 35 kilograms 77 lb 1 3 It contains lamivudine and tenofovir disoproxil 1 It is taken by mouth 1 Lamivudine tenofovirCombination ofLamivudineNucleoside reverse transcriptase inhibitorTenofovir disoproxilNucleotide reverse transcriptase inhibitorClinical dataTrade namesCimduo TemixysAHFS Drugs comMonographMedlinePlusa618039License dataUS DailyMed CimduoRoutes ofadministrationBy mouthATC codeJ05AR12 WHO Legal statusLegal statusUS only 1 2 IdentifiersKEGGD11395Lamivudine tenofovir was approved for medical use in the United States in February 2018 1 4 References Edit a b c d e Cimduo lamivudine and tenofovir disoproxil fumarate tablet film coated DailyMed 22 March 2018 Retrieved 26 March 2020 Temixys lamivudine and tenofovir disoproxil fumarate tablet film coated DailyMed Retrieved 13 February 2022 Waters L Mehta V Gogtay J Boffito M March 2021 The evidence for using tenofovir disoproxil fumarate plus lamivudine as a nucleoside analogue backbone for the treatment of HIV Journal of Virus Eradication 7 1 100028 doi 10 1016 j jve 2021 100028 PMC 7868802 PMID 33598310 Drug Approval Package Cimduo lamivudine and tenofovir disoproxil fumarate U S Food and Drug Administration FDA 27 November 2018 Retrieved 26 March 2020 Further reading Edit WHO Public Assessment Report HA414 Lamivudine Tenofovir disoproxil fumarate 300mg 300mg Tablets Mylan Laboratories Ltd India World Health Organization WHO Archived from the original on 26 March 2020 External links Edit Lamivudine Drug Information Portal U S National Library of Medicine Tenofovir disoproxil Drug Information Portal U S National Library of Medicine Tenofovir disoproxil fumarate Drug Information Portal U S National Library of Medicine Portals Medicine Viruses This antiinfective drug article is a stub You can help Wikipedia by expanding it vte Retrieved from https en wikipedia org w index php title Lamivudine tenofovir amp oldid 1123266375, wikipedia, wiki, book, books, library,
